Related Experiment Video
Updated: Jul 20, 2025

Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement
Milorad Zivkovic1, Sara Tomovic2, Ivan Busic2
1Cardiology Clinic, University Clinical Center of Serbia, Belgrade, Serbia.
Insights
Acute coronary syndromes (ACS) after transcatheter aortic valve replacement (TAVR) have unique causes and poorer outcomes. This review examines ACS incidence, mechanisms, and treatment in TAVR patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Research
Background:
- Transcatheter aortic valve replacement (TAVR) is increasingly used in younger, lower-risk patients, leading to longer survival.
- Longer life expectancy post-TAVR increases the risk of future acute coronary events (ACS).
- ACS in TAVR patients differs clinically from non-TAVR populations, with unique underlying mechanisms.
Purpose of the Study:
- To review current data on ACS incidence, timing, and mechanisms following TAVR.
- To analyze the causes of ACS in patients with prior TAVR procedures.
- To examine optimal invasive treatment strategies and clinical outcomes for ACS in TAVR patients.
Main Methods:
- Comprehensive literature review of studies investigating ACS after TAVR.
- Analysis of reported incidence, timing, and etiological factors of ACS in TAVR recipients.
- Evaluation of treatment approaches and short- and long-term outcomes.
Main Results:
- Plaque rupture is a primary ACS cause, but nonatherothrombotic mechanisms (emboli, valve obstruction) are more frequent in TAVR patients.
- TAVR patients with ACS undergo invasive management less frequently.
- ACS in TAVR patients is linked to worse prognosis, higher mortality, and increased major adverse cardiovascular events (MACE).
Conclusions:
- ACS following TAVR is an understudied but significant clinical issue with distinct characteristics and poor outcomes.
- Understanding the unique mechanisms of ACS post-TAVR is crucial for developing effective management strategies.
- Further research is needed to optimize treatment and improve prognosis for TAVR patients experiencing ACS.
Abstract:
Extending the indication of transcatheter aortic valve replacement (TAVR) to younger and lower-risk patients naturally results in longer life expectancy and survival rates after the intervention. The longer life expectancy of these patients leads to an increased possibility of future acute coronary events, necessitating the development of effective and appropriate treatment strategies. Acute coronary syndromes (ACS) in patients with previous TAVR procedures present with modified clinical characteristics when compared to the non-TAVR population. In populations with prior TAVR procedures, plaque rupture remains the main cause of ACS. However, unlike the non-TAVR population, there is an increased frequency of nonatherotrombotic mechanisms, like emboli and mechanical obstruction of coronary ostia by valve components. The main observation related to the treatment of ACS TAVR patients is the significantly lower percentage of patients undergoing invasive management. Furthermore, ACS in TAVR patients is associated with poor prognosis, higher long-term mortality rates, and higher incidence of MACE. It is surprising that considering this significant and increasingly recognized issue, there are only a few studies that have investigated ACS after TAVR. The scope of the present review is to address available data about ACS following TAVR, focusing on incidence, timing, mechanism, and causes. We also examined current knowledge regarding optimal invasive treatment and analyzed short and long-term clinical outcomes.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Aortic Regurgitation III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Aortic Regurgitation I: Introduction

